Table 5. Risk factors for pediatric intensive care unit admission in children infected with Mycoplasma pneumoniae, Ohio, USA, 2015–2019*.
| Risk factor |
Univariate analysis |
|
|---|---|---|
| OR (95% CI) |
p value |
|
| Female sex | 1.13 (0.5–2.55) | 0.7754 |
| Age, y | 0.98 (0.9–1.08) | 0.7206 |
| Underlying condition | 4.32 (1.72–10.88) | 0.0019 |
| Any previous visit | 3.73 (1.31–10.62) | 0.0138 |
| Macrolide resistance | 5.34 (1.39–20.55) | 0.015 |
| Abnormal respiratory examination | 5.34 (1.41–20.21) | 0.0137 |
| Previous treatment with antimicrobial drugs | 3.17 (1.38–7.27) | 0.0066 |
| Previous nonmacrolide antimicrobial drugs | 2.81 (1.23–6.42) | 0.014 |
| Positive viral test | 0.79 (0.31–2.01) | 0.6127 |
| MRMp and positive viral test | 2.11 (0.27–16.71) | 0.4805 |
*Bold type indicates statistical significance. MRMp, macrolide-resistant Mycoplasma pneumoniae; OR, odds ratio.